 | Administrators: Please do not delete this category as empty! This category may be empty occasionally or even most of the time. |
 FA |  A |  GA | B | C | Start | Stub | FL | List | Category | Disambig | Draft | File | Portal | Project | Template | NA | ??? |
| 6 | 0 | 30 | 368 | 776 | 1,089 | 495 | 0 | 44 | 278 | 2 | 18 | 4 | 0 | 13 | 111 | 96 | 18 |
Pages in category "Template-Class women's health articles"
The following 111 pages are in this category, out of 111 total. This list may not reflect recent changes.
A
- Template talk:Abortion
- Template talk:Abortion by US state
- Template talk:Affinities of estrogen receptor ligands for the ERα and ERβ
- Template talk:Affinities of selected androgen receptor ligands
- Template talk:Androgen replacement therapy formulations and dosages used in women
- Template talk:Androgen/anabolic steroid dosages for breast cancer
- Template talk:Androgens and antiandrogens
- Template talk:Available forms of estradiol
- Template talk:Available forms of progesterone
- Template talk:Available forms of testosterone
B
C
- Template talk:Chemical structures of equine estrogens
- Template talk:Chemical structures of major endogenous estrogens
- Template talk:Chemical structures of major endogenous estrogens medication version
- Template talk:Composition of conjugated estrogens and properties of constituents
- Template talk:Congenital malformations and deformations of breast
- Template talk:Cyproterone acetate
E
G
H
- Template talk:Hormonal contraceptives
- Template talk:Hormone levels during pregnancy in human females
- Template talk:Hormone levels in gonadally intact adolescent and adult females with complete androgen insensitivity syndrome
- Template talk:Hormone levels with estradiol and estradiol esters by intramuscular injection
- Template talk:Hormone levels with estradiol benzoate/estradiol dienanthate/testosterone enanthate benzilic acid hydrazone by intramuscular injection
- Template talk:Hormone levels with oral estradiol
- Template talk:Hormone levels with sublingual estradiol
- Template talk:Hormone levels with transdermal estradiol patches
M
P
- Template talk:Parenteral durations of androgens/anabolic steroids
- Template talk:Parenteral potencies and durations of nonsteroidal estrogens
- Template talk:Parenteral potencies and durations of progestogens
- Template talk:Pathology of pregnancy, childbirth, and the puerperium
- Template talk:Pediatrics-journal-stub
- Template talk:Pediatrics-stub
- Template talk:Pharmacodynamics of aromatase inhibitors
- Template talk:Pharmacodynamics of progestogens
- Template talk:Pharmacokinetic parameters of progesterone by different routes
- Template talk:Pharmacokinetics of 100 mg per day spironolactone and its metabolites
- Template talk:Pharmacokinetics of progestogens
- Template talk:Pharmacokinetics of three estradiol esters by intramuscular injection
- Template talk:Pharmacological properties of major anabolic steroids
- Template talk:Plasma estrogen levels after a single dose of conjugated estrogens by different routes
- Template talk:Plasma estrogen levels after a single dose of estradiol by different routes
- Template talk:Plasma protein binding of testosterone and dihydrotestosterone
- Template talk:Potencies and durations of natural estrogens by intramuscular injection
- Template talk:Pregnancy
- Template talk:Pregnancy and mental health
- Template talk:Progesterone
- Template talk:Progesterone metabolism
- Template talk:Progestogens and antiprogestogens
- Template talk:Protein binding and metabolic clearance rates of estrogens
- Template talk:Published case reports of cyproterone acetate-associated liver toxicity
- Template talk:Published case reports of cyproterone acetate-associated meningioma
- Template talk:Published case reports of cyproterone acetate-associated prolactinoma
R
- Template talk:Relative affinities of anabolic steroids and related steroids
- Template talk:Relative affinities of estrogens for steroid hormone receptors and blood proteins
- Template talk:Relative affinities of hydroxyprogesterone and related steroids
- Template talk:Relative affinities of levonorgestrel and metabolites
- Template talk:Relative affinities of nandrolone and related steroids
- Template talk:Relative affinities of norethisterone, metabolites, and prodrugs
- Template talk:Relative affinities of noretynodrel, tibolone, and metabolites
- Template talk:Relative affinities of normethandrone and metabolites
- Template talk:Relative androgenic to anabolic activity in animals
- Template talk:Relative oral potencies of estrogens
- Template talk:Results of the Women's Health Initiative menopausal hormone therapy randomized controlled trials
- Template talk:Risk of breast cancer with menopausal hormone therapy by duration in large observational studies
- Template talk:Risk of breast cancer with menopausal hormone therapy in large observational studies
- Template talk:Risk of venous thromboembolism with hormone therapy and birth control pills (QResearch/CPRD)
S
- Template talk:Selected biological properties of endogenous estrogens in rats
- Template talk:Side effects of estrogen plus high- versus low-dose cyproterone acetate in women
- Template talk:Side effects of high-dose cyproterone acetate
- Template talk:Side effects of spironolactone in women in clinical studies for acne
- Template talk:Spironolactone
- Template talk:Spironolactone at steroid hormone receptors
- Template talk:Structural aspects of androgens and anabolic steroids
- Template talk:Structural aspects of progestogens used in clinical and veterinary medicine
- Template talk:Structural properties of selected estradiol esters
T
- Template talk:Target ranges for hormone levels in hormone therapy for transgender women
- Template talk:Testosterone
- Template talk:Testosterone levels in males and females
- Template talk:Testosterone levels with cyproterone acetate
- Template talk:Tissue-specific estrogenic and antiestrogenic activity of SERMs
- Template talk:Transdermal estradiol patches marketed in the United States